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Once referred to as “normal commensal flora” the human microbiome plays an integral
role between health and disease. The host mucosal surface replete with a multitude of
immune cells is a vast arena constantly sensing and responding to antigen presentation
and microbial by-products. It is this key role that may allow the microbiome to prime
or protect the host from autoimmune disease. Rheumatoid arthritis (RA) is a chronic,
disabling inflammatory condition characterized by a complex multifactorial etiology. The
presence of certain genetic markers has been proven to increase susceptibility to RA
however it does not guarantee disease development. Given low concordance rates
demonstrated in monozygotic twin studies there is a clear implication for the involvement
of external players in RA pathogenesis. Since the historical description of rheumatoid
factor, numerous additional autoantibodies have been described in the sera of RA
patients. The presence of anti-cyclic citrullinated protein antibody is now a standard test,
and is associated with a more severe disease course. Interestingly these antibodies are
detectable in patient’s sera long before the clinical signs of RA occur. The production
of autoantibodies is driven by the lack of tolerance of the immune system, and how
tolerance is broken is a crucial question for understanding RA development. Here we
review current literature on the role of the microbiome in RA development including
periodontal, gut and lung mucosa, with particular focus on proposed mechanisms of
host microbiome interactions. We discuss the use of Mendelian randomization to assign
causality to the microbiome and present considerations for future studies.
Keywords: Initiation of autoimmunity, host-microbiome interaction, gut microbiome, oral microbiome, lung
microbiome, rheumatoid arthritis
INTRODUCTION
Complex interactions govern the symbiosis that exists between the human body as the
host and our microbiome. It is conceivable to imagine that defense mechanisms capable of
continual surveillance for infection but tolerant of our own “healthy microbiome” have evolved
(Kamada et al., 2013; Mezouar et al., 2018), allowing the microbiome to prime or protect
us from disease. Initial microbiome research focused on descriptions of variant microbiome
populations within specific disease states, e.g., diabetes, obesity, inflammatory bowel disease
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(Tilg and Moschen, 2014; Tralongo et al., 2014; Tomasello et al.,
2015; Castaner et al., 2018; Sharma and Tripathi, 2019) or
temporal shifts observed over the course of a disease (Kong et al.,
2012; Kelly et al., 2016). Autoimmune disorders are a primary
group of disorders hypothesized to be triggered by interactions
of the microbiome and the host (Chervonsky, 2013). Intriguingly
the target tissue which characterizes the clinical syndrome is
often distant from the assumed instigating microbial impetus,
this scenario is exemplified by rheumatoid arthritis (RA).
As the number of microbiome studies increase and greater
details unfold regarding the microbiomes’ physiological role we
believe it is important to emphasize two elements of microbiome
research. Firstly, strictly speaking the term microbiome refers
to all microorganisms and the collection of all their genes and
genomes within a microbial community associated with a distinct
anatomical region (Lederberg and Mccray, 2001). Therefore
this definition would encompass all living organisms at that
site, including bacterial, viral, fungal and archaeal populations.
This is an important concept as tools for analysis of these
complex communities can be divided broadly into functional
or taxonomic characterization. Primarily, the former relies on
metagenomic shotgun sequencing and the latter on 16S rRNA
sequencing but overlap exists, where hypothesized function
can be inferred from 16S rRNA sequencing (Ortiz-Estrada
et al., 2019) and of course, metagenomics shotgun sequencing
is also capable of taxonomic resolution. Taxonomic variation
using 16S rRNA often only reports the bacterial portion of
the microbiome, albeit the largest and potentially most active
microbial component. It is worth noting the fungal, viral and
much of the archaeal populations are not reported in 16S rRNA
analysis performed. Secondly, it is often cited that the gut
microbiome houses up to 1014 bacterial cells. While there is
agreement that the gut microbiome is indeed the largest human
microbiome in terms of cell biomass and genetic potential,
the original estimates of bacterial cells outnumbering human
cells by 10:1 is likely an over estimation (Sender et al., 2016).
Sender et al. (2016) investigated these numbers and found the
original estimates stemmed from a single paper published in
1972 (Luckey, 1972) which assumed a homogenous bacterial
population density along the alimentary canal, and overestimated
the capacity of the human colon thereby amplifying bacterial
numbers. Newer estimates suggest a more modest ratio of 1:1 of
bacterial to human cell biomass (Sender et al., 2016), however this
of course this does not take into account genetic potential and
subsequent metabolic pathways which still favor the microbiome
as having numerical dominance in terms of transcriptional and
subsequent functional activity.
This review article focuses on the mechanistic relationships
between the microbiome and the human host and how bacterial
perturbations could trigger or potentiate the autoimmune
response in RA. Building upon previous review articles
(Rosenbaum and Asquith, 2016; Wells et al., 2019; Konig, 2020)
we have included a synopsis of the unique immune adaptions
at potential offending mucosal sites, focusing on the molecular
interactions and a summary of the animal model supporting the
mucosal origins hypothesis of RA. We highlight potential new
efforts to assign causality to the microbiome using Mendelian
randomization on available curated datasets and finally propose
some future consideration for further research.
THE MICROBIOME AND RA
AUTOIMMUNITY
Numerous factors impact the microbiome such as vaginal
delivery versus cesarean section in newborns, diet, and antibiotic
administration (Hasan and Yang, 2019) with the overriding
determinant being anatomical site (Cho and Blaser, 2012).
The diversity of a microbiome can be categorized based on
which organisms are present, their relative abundance, their
temporality and their metabolic activity. Great variation of the
microbiota between individuals, and even temporally within
the same individual has been demonstrated at the lower
taxonomic units (Costello et al., 2009). Each of these streams
holds the potential for disease progression or enhancement. For
example, the priming of the immune system with a specific
antigen exposure or infection with a predominant bacterium
and subsequent induction of a pro-inflammatory status could
impact disease states.
Rheumatoid arthritis is a chronic, disabling autoimmune
disease characterized by a complex multifactorial etiology.
The presence of certain genetic markers has been proven to
increase susceptibility to RA, however these do not guarantee
RA development (Stahl et al., 2010). A 15% concordance has
been demonstrated in monozygotic twin studies which clearly
indicates a role for environmental factors in disease development
(Aho et al., 1986). Furthermore the use of antimicrobials in
RA treatment has been established for some time, (Brown
et al., 1971) however, the exact mechanism by which they exert
their effect is unknown, as is the target group of organisms
(Nagra et al., 2019). The production of autoantibodies is driven
by the lack of tolerance of the immune system, and how
tolerance is broken is a crucial question for understanding RA
development. Since the historical description of rheumatoid
factor (RF), an IgM antibody directed against IgG, numerous
additional autoantibodies have been described in the sera of
RA patients. These autoantibodies are directed against various
joint components (cartilage, collagen) and non-joint components
(enzymes, nuclear proteins, stress proteins) and although are not
diagnostically important may contribute to disease by immune
complex formation and deposition. The presence of anti-cyclic
citrullinated protein antibody (ACPA) is now a standard test
for RA, and is associated with a more severe disease course.
Interestingly these antibodies are detectable in patient’s sera
long before the clinical signs of RA (i.e., clinical arthritis)
occur (Nielen et al., 2004). Within this phase of antibody
positivity but without arthritis, the joint synovium shows no
inflammatory changes (Berglin et al., 2006; Van De Sande et al.,
2011). ACPA represent a collection of autoantibodies of various
isotypes (IgG, IgM, and IgA) directed against the neutrally
charged non-essential amino acid citrulline. The creation of
ACPA’s is brought about by a process called citrullination,
which is the post-translational modification of arginine, catalyzed
by peptidylarginine deiminase (PAD) enzymes resulting in the
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substitution of arginine to citrulline. This process decreases
the proteins ability to form hydrogen bonds due to a lack of
positively charged amino acids introducing a structural change
within the peptide sequence and subsequent immunogenicity
(Kurowska et al., 2017). PAD enzymes are highly conserved
throughout evolution, in humans there are five main types of
PAD genes (Chavanas et al., 2004) which display both tissue
and substrate specificity and are involved in a plethora of
physiological functions including tissue structure, apoptosis and
immune regulation (Wegner et al., 2010), of note PAD2 and
PAD4 are likely more important in RA development given their
isolation in the synovium of RA patients (Foulquier et al., 2007).
As mentioned ACPA’s may be heterogeneous in terms of their
fine specificity to antigens but are highly specific for RA when
compared to RF (Kurowska et al., 2017).
The presence of circulating serum ACPA represent a state
of systemic autoimmunity, combination of ACPA titers with
symptomatology, imaging and major histocompatibility complex
(HLA)-DRB1, prediction models can be developed to identify
those at the highest risk of progression to RA (Van De Stadt
et al., 2013; Rakieh et al., 2015). As previously mentioned, the
multifactorial etiology of RA encompasses genetic risk, with the
“shared epitope” (SE) accounting for the strongest genetic risk
factor (Gregersen et al., 1987; Raychaudhuri et al., 2012; Deane
et al., 2017). The SE is located within the third hypervariable
region of HLA DRB1 molecule and encodes a five amino acid
sequence (Huizinga et al., 2005) with some alleles possessing
a higher binding affinity for citrullinated peptides spurring the
investigation for a “RA antigen.” The identification of such an
antigen is an exciting concept which may provide a malleable risk
factor in which RA disease may be moderated or ameliorated.
Environmental risk factors are a perpetual interest in RA, as
mentioned the use of drugs with antimicrobial properties for
the treatment of RA (Ogrendik, 2013) provide a rationale for
a possible role of bacteria in RA pathogenesis. Furthermore,
infections with specific organisms have been associated with an
increased risk of RA development; these include Porphyromonas
gingivalis (discussed within “Periodontal Microbiome and ACPA”
section), Proteus mirabilis, Mycobacterium tuberculosis, and
Mycoplasma spp. (Li et al., 2013) the hypothesized mechanism
of action includes molecular mimicry and activation of the
immune system via a “super-antigen.” Recently gastrointestinal
and urogenital infections were shown to be associated with a
lower risk developing RA (Sandberg et al., 2015). The authors’
hypothesize that these infections and/or their subsequent
treatment with antibiotics may induce a deviation in microbiome
composition that has an overall protective effect i.e., disrupting
an already high risk microbiome. Smoking status has a
long established link with RA as demonstrated by numerous
epidemiological studies (Karlson et al., 1999; Criswell et al., 2002;
Padyukov et al., 2004; Sugiyama et al., 2010), this combined
with the strong link to periodontal disease (PD) (Kasser et al.,
1997; Mercado et al., 2001; Pischon et al., 2008; Scher et al.,
2012; Äyräväinen et al., 2017) provides clear evidence for
the role of the oral microbiome in the development of RA.
Continuing along the lines of a microbial impetus for RA,
Scher et al. (2013) demonstrated individuals diagnosed with
new onset RA had a different microbiome when compared
to healthy controls, while Zhang et al. (2015) demonstrated
perturbations in both the oral and gut microbiomes could be
used to identify those with RA from healthy controls. They
also demonstrated that treatment of RA with disease modifying
drugs resulted in reversion of the microbiome composition
comparable to that of the healthy controls, which undoubtedly is
a secondary phenomenon but serves to highlight the interaction
between the gut microbiome and joint inflammation. Therefore,
understanding the microbiomes role will be paramount in
completing this etiological puzzle of RA. In this review we
will focus on the mechanisms by which the microbiome may
initiate autoimmunity.
THE NICHE ENVIRONMENT OF THE
MICROBIOME
The oral microbiome acts a portal of entry to the human body
and therefore has adapted to endure a multitude of physical
insults including rapid fluctuations in temperature, pH and
external pollutants (air and climate) (Idris et al., 2017). The
oral cavity forming the initial segment of the alimentary canal
shares many physiological features with the gastrointestinal tract,
and indeed the function of gastrointestinal immune cells is far
better understood. Distinct to the oral cavity, salivary secretions
are a primary component of the oral immune system, and have
evolved with the ability to rapidly neutralize microbial threats
via the production of large quantities of secretory IgA, mainly
in a dimeric form (Brandtzaeg, 2013). The unique properties
of the secretary IgA allows it to resist proteolytic cleavage
while preventing bacterial aggregation and biofilm formation, a
precursor to PD. Stimulus for the production of the IgA comes
from inductor sites such as mucosa-associated lymphoid tissue
(MALT) (Wu et al., 2014) in particular nasopharynx-associated
lymphoid tissue (Brandtzaeg et al., 1999).
The gastrointestinal (GI) tract is a unique organ providing
a pivotal dual role of digestion and maintenance of immune
homeostasis. The enormous numbers of antigens presented to
the GI tract in the form of food, environmental and microbial
antigens are processed at the highly efficient mucosal barrier,
which can be divided into three physically distinct elements;
the epithelial barrier, the lamina propria and the gut-associated
lymphoid tissue (GALT). GALT is further divided into payer’s
patches (PP), isolated lymphoid follicles and mesenteric lymph
nodes (MLN) which together constitute the largest lymphatic
network in the body (Mowat, 2003; Ahluwalia et al., 2017). There
are a variety of mechanisms by which the gut is capable of antigen
uptake. Briefly antigens can enter via microfold (M) cells and are
presented by dendritic cells (DC) to underlying T cells within
the PP. Alternatively the DC may enter the lymphatic drainage
network and present to next MLN. Direct intraluminal antigen
sampling may also occur as DC are capable of extending the
dendrite through the epithelial barrier directly into the colonic
lumen. Furthermore, follicular associated enterocytes may pass
antigens to DC cells or via MHC class II presentation to CD4+
cells (Ahluwalia et al., 2017) see Figure 1. The first line of
Frontiers in Cell and Developmental Biology | www.frontiersin.org 3 September 2020 | Volume 8 | Article 538130
fcell-08-538130 September 26, 2020 Time: 18:57 # 4
Rooney et al. The Microbiome and RA Autoimmunity
immune defense relies on a family of receptors known as pattern
recognition receptors (PRR’s), these receptors are expressed on
innate immune cells and include Toll-Like receptors (TLR) which
allow identification of pathogen-associated molecular patterns
(PAMPs). Upon sensing a PAMP, TLR enables activation of
the immune system and induces subsequent inflammation to
eradicate the invading organism (Kumar et al., 2011; Ahluwalia
et al., 2017), is it through PAMPs that the mucosal immune
system maintains constant surveillance.
Akin to the gastrointestinal system, the mucosal surface of the
lung is also exposed to a vast array of antigens, hence the resident
immune cells of the bronchial tree must also delineate between
potential harmful and innocuous stimuli (Joshua et al., 2017).
The lung mucosal barrier in addition to recognition of PAMP’s
during pathogen invasion, can also identify damage-associated
molecular patterns (DAMP’s) commonly induced by smoking,
which may further perpetuate PAMP recognition and subsequent
TLR activation (Joshua et al., 2017). Within the lungs, local
inflammation fosters the development of inducible bronchus
associated lymphoid tissue (iBALT) which is architecturally
similar to other non-encapsulated secondary lymphoid structures
(PP), having distinct B and T cell elements with supporting
APC’s (Carragher et al., 2008). The presence of iBALT therefore
confers the mucosal lining of the lungs the ability to generate and
potentiate autoantibody production.
MURINE MODELS OF RA
Although the focus of this review is on human studies, it
would be remiss not to cover the three main rodent models
[collagen induced arthritis (CIA), K/B×N, and SKG] of RA
and microbiome research as these studies offer the unique
ability for microbial manipulation, and therefore an attractive
avenue for mechanistic insights. Within each mucosal section
we have included additional important animal studies. Rogier
et al. (2017) used a CIA mouse model to investigate the gut
microbiome in the pre-RA state. Briefly the CIA murine model
is created via immunization of genetically susceptible (DBA/1)
mice with type II collagen resulting in a polyarthritis which is
both clinically and histologically similar to RA (Brand et al.,
2004). Within the preclinical phases of RA a relative decrease in
Bacteroidetes and Bacteroidaceae was identified, while Firmicutes
and Proteobacteria (Ruminococcaceae, Lachnospiraceae, and
Desulfovibrionaceae) were increased during the immune-priming
phase of arthritis (Rogier et al., 2017). Following elimination of
microbial populations (antibiotics) the abundance of intestinal
Th17 cells decreased with subsequent attenuation of arthritis.
Dynamic temporal microbial changes in this pre-RA phase
have also been demonstrated using CIA mouse models (Jubair
et al., 2018), with an initial decrease in Bacteroidetes and an
increase in Lactobacillaceae; however, by day 35 of the model
(early induction of arthritis at day 14) Lactobacillaceae had
returned to day 0–7 levels, while Lachnospiraceae significantly
increased in abundance. The authors found mucosal IL-17A and
IL-22 increased on day 14, corresponding to the decreases in
Bacteroidetes and increases in Lactobacillaceae and subsequently
normalized on day 35, as bacterial abundances of Bacteroidetes
and Lactobacillaceae returned to day 0 levels (Jubair et al., 2018).
Some Lactobacillaceae are known to have a regulatory effect
on the immune system, for example Lactobacillus salivarius
and Lactobacillus plantarum transferred to mice prior to the
induction of CIA reduced Th17 cells and increased Treg cells
resulting in reduced arthritis severity (Liu et al., 2016). As
discussed later, L. salivarius has been associated with new
onset RA in humans. Depletion of microbial load using broad
spectrum antibiotics resulted in decreased disease duration and
decreased antibody production (Jubair et al., 2018) which was
true for both early and late antibiotic administration. Of note,
later administration of antibiotics, following the second CIA
inoculation, had a greater reduction in disease severity. The
anti-inflammatory effect of the reduced microbial load has
been attributed to decreased glycosylation of the FC portion of
mucosal autoantibodies with subsequent decreased compliment
activation leading to decreased inflammation (Jubair et al., 2018).
Pfeifle et al. (2017) has shown antibody glycosylation to be
an important factor in the transition between asymptomatic
autoimmunity and symptomatic disease in RA patients and in
CIA and K/B×N models. Tong et al. (2020) demonstrated the
microbiome of pre-RA individuals (ACPA positive) was capable
of inducing gut mucosal changes in a CIA mouse model. There
was significant decreases in Zo-1 gene expression combined
with mucosal damage and increases in mucosal Th17 cells, mice
inoculated with the pre-RA microbiome displayed earlier and
more severe joint disease in comparison to those inoculated with
the microbiome from healthy controls (Tong et al., 2020).
The K/B×N mouse model possess a transgenic T-cell receptor
and the MHC class II molecule Ag7 resulting in spontaneous
arthritis due to the production of autoantibodies against the
ubiquitous protein glucose-6-phophate isomerase (Ditzel, 2004).
Under germ free conditions, autoimmune arthritis in the
K/B×N mice was significantly attenuated, with absence of
Th17 cells within the gut mucosa. Inoculation with segmented
filamentous bacteria (SFB) reinstated the Th17 cell population
and the arthritis phenotype (Wu et al., 2010). In keeping
with previous experiments demonstrating colonization with
SFB and their ability to induce a proinflammatory state
(Ivanov et al., 2009). Thompson et al. (2012) has investigated
the taxonomic relationships of SFB and demonstrated those
observed in vertebrates to be a distinct linage within the family
clostridiaceae, suggesting the term Candidatus Savagella to be
used in future to denote SFB in vertebrates. It is interesting to
note that within Thompson et al. (2012) study, SFB observed
in arthropods were shown to be a distinct linage within the
family lachnospiraceae, which has been implicated in the above
CIA models. The presence of SFB has been confirmed in the
human gut and shown to be associated with increased IgA
levels (Chen et al., 2018). Flak et al. (2019) used K/B×N to
gain mechanistic insights into the loss of gut homeostasis and
showed that arthritic mice had increased gut permeability due
to decreased presence of tight junctions and goblet cells when
compared to naive mice. They noted downregulation of the
gut-protective mediator D5n-3 DPA (RvD5n-3 DPA) and IL-10
expression corresponding with the above physiological changes
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FIGURE 1 | Sent in a different document as requested. Depiction of the role of the oral and gut microbiomes on RA. Oral dysbiosis may increase the burden of
citrullination via direct and indirect mechanisms through key pathogens Porphyromonas gingivalis and Aggregatibacter actinomycetemcomitans. The gut epithelia
presents antigens to the underlying immune cells via Microfold cells (M cells) and subsequently to mesenteric lymph nodes (MLN) via dendritic cells (DC) situated in
the payer’s patches (PP) within the lamina propria. DC may also sample antigens directly by extension of a dendrite directly in the colonic lumen. Alternative CD4+ T
cells may be activated directly by follicular associated enterocytes. This immune activation leads to cytokine production and stimulation of pro-inflammatory T cells
(Th17) resulting in B cell activation and antibody production. Anti-cyclic citrullinated protein antibody (ACPA). ACPA’s produced in both the oral cavity and the gut can
enter circulation, migrate to the joints and contribute to RA development.
in the gut mucosal. Following inoculation with P. gingivalis
further decreases of both RvD5n-3 DPA and Il-10 levels were
identified with further disruption of the gut permeability, these
changes were reversed upon supplementation with RvD5n-3
DPA restoring gut barrier function, suggesting an additional
mechanistic role for P. gingivalis in RA development.
A third mouse model; the SKG model [a missense mutation in
Zap70 resulting in spontaneous arthritis (Sakaguchi et al., 2003)]
has demonstrated induction of arthritis following inoculation
of SKG mice with the gut microbiome of early RA patients
(Maeda et al., 2016). Germ free SKG mice were either inoculated
with pooled feces from healthy controls or early RA patients.
A predominance of Prevotella copri (discussed later in this
review) was identified with within the early RA patients, which
was corroborated within the mice receiving the RA microbiome
following inoculation and associated with increased Th17 cells
and arthritis severity (Maeda et al., 2016). As previous stated,
mouse models provide a malleable environment in which to
ascertain mechanistic insights into the microbiome’s ability to
induce disease, and remain the gold standard of establishing
causality in microbiome research (Round and Palm, 2018).
However, some caution should be taken given a substantial
number of taxa within the human gut fail to colonize the
engrafted animal (Zhang et al., 2017), and those that do
colonize may foster community structures distinct from the
human donor (Staley et al., 2017). Finally, as exemplified by
the multifactorial etiology of RA, the ecological factors (diet,
lifestyle, genotype) driving the dysbiosis in humans are lacking
in the murine models making it difficult to replicate human-
microbiome disease associations (Arrieta et al., 2016).
PERIODONTAL MICROBIOME AND
ACPA
Periodontal disease is characterized by environmental risk factors
(smoking), genetic risk factors [shared epitope (Marotte et al.,
2006)] and persistent inflammation leading to bony destruction,
all characteristics shared with RA. We have already highlighted
the epidemiological links demonstrating RA patients to have
increased prevalence and severity of PD. The fact that PD
exists at the time of diagnosis of new RA (Scher et al., 2012;
Mankia et al., 2019) suggests it is less likely a consequence of
the RA disease process, but possibly an additional target of the
disease or a disease initiator. Scher et al. investigated the oral
microbiome in new onset RA (NORA) patients prior to disease
treatment, and compared it to chronic RA patients and healthy
controls. Interestingly there was no difference in the microbiome
diversity of the NORA and the other groups, however two taxa,
Prevotella spp. and letotrichia spp. were enriched in NORA
patients regardless of PD status. Investigating groups at risk of
developing RA allows us to examine disease chronology and
investigate disease initiation, before clinical arthritis occurs. This
is a unique time point which is unattainable in most disease
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TABLE 1 | Possible mechanism of microbial influence on RA development.
Study Link to RA Methodology Findings
Maresz et al., 2013; Gully et al., 2014;
Sandal et al., 2016; Courbon et al.,
2019
PPAD citrullination Rodent arthritis model Infection with P. gingivalis aggravated arthritic
symptoms
Konig et al., 2016 Citrullination via
A. actinomycetemcomitans
Mass spectrometry Neutrophilic hypercitrullination induced by pore
forming toxin Lt×A.
Moutsopoulos et al., 2012 Pro-inflammatory cytokine
production leading to osteoclastic
activation
In-vitro cytokine production Increased Th17 and IL17 production on
exposure to P. gingivalis
Sato et al., 2017; Tsukasaki et al., 2018 Pro-inflammatory cytokine
production leading to osteoclastic
activation
Rodent model Increased Th17 and IL17 production on
exposure to P. gingivalis
Lundberg et al., 2008 Molecular mimicry ELISA, mass spectrometry Cross-reactivity between human α-enolase and
P. gingivalis α-enolase
Khandpur et al., 2013 Citrullination via NETosis Neutrophils isolated via
sedimentation and quantification via
fluorescence microscopy
Increased NETosis in RA patients. NETosis
correlated with ACPA presence.
Totaro et al., 2013 Bacterial translocation PCR Presence of P. gingivalis DNA in synovial tissue
Taurog et al., 1994 Toll like receptor activation Rodent model Arthritis development was dependant on LTR
activation by Lactobacillus bifidus
Chen et al., 2016 Disease prediction model based on
random forest plots.
16S rRNA sequencing in humans.
Rodent model used to investigate
causality
Collinsella, Eggerthella, and Faecalibacterium
identified as predictor organisms of RA.
Collinsella increase disease severity in rodent
models
Kim et al., 2018 Osteoclastic activity inhibited by
butyrate
Rodent model Butyrate inhibited HDAC2 in osteoclast and
HDAC8 in T cells. Control of Th17/Treg balance.
processes. Mankia et al. demonstrated increased prevalence of
PD in ACPA+ at-risk individuals when compared with early RA
patients and healthy matched controls (Mankia et al., 2019).
The strongest evidence linking both PD and RA comes
in the form of the enzyme PAD. This enzyme has been
identified in the organism P. gingivalis part of the “red
complex” of dental organisms known to cause PD (Mcgraw
et al., 1999). Interestingly the genes encoding PAD enzymes
in P. gingivalis (PPAD) share no sequence homology to
human PAD genes and to date P. gingivalis is the only
bacteria identified containing such genes (Gabarrini et al.,
2015). PPAD possesses the same catalytic activity of the
human PAD enzymes resulting in citrullination, however PPAD
shows preference to the terminal and free arginine residues.
This is an important differentiation from human PAD genes
(which endocitrullinate) as one of the proposed mechanisms
in which P. gingivalis induces arthritis is via the release of
the virulence factor arginine-gingipanis (RpgB) which cleaves
host proteins exposing the terminal arginine residue which is
then free to undergo citrullination via PPAD with the creation
of neo-epitopes and subsequent ACPA positivity (Wegner
et al., 2010). This hypothesis is supported by murine models
which demonstrated that mice with laboratory induced arthritis
had higher autoantibody production and joint destruction in
those infected with wild type PPAD compared to those with
mutated deficient PPAD genes (Maresz et al., 2013; Gully
et al., 2014; Sandal et al., 2016; Courbon et al., 2019). Sandel
et al. demonstrated this pathway was restricted via HLA-DRB1
positive mice suggesting that in addition to the presence of
P. gingivalis and its associated expressed virulence factors,
a genetic predisposition was also required. Remaining on
the theme of citrullination, another oral pathogen has been
recently identified as a possible etiological agent, Aggregatibacter
actinomycetemcomitans (Konig et al., 2016). This organism is
typically associated with aggressive PD or endocardial disease.
Leukotoxin A (LtxA) is a primary virulence toxin produced by
A. actinomycetemcomitans capable of inducing pore formation
into the cell membrane of neutrophils, the resultant transient
membrane permeability can then induce dysregulation of human
PAD enzymes due to a rapid influx of calcium leading to
increased endogenous citrullination, however not shown to
be increased in ACPA positive population progressing to
RA see Figure 1.
P. gingivalis has also been linked to increased production of
Th17 cells (Moutsopoulos et al., 2012), a subset of CD4+ cells
that have gained much attention in the field of autoimmunity
since their identification in Harrington et al. (2005). The primary
role of Th17 cells is fighting bacterial (mainly Staphylococcus
aureus) and fungal (mainly Candida albicans) infections
(Holland et al., 2007; De Beaucoudrey et al., 2008). Th17 cells
are capable of producing a repertoire of pro-inflammatory
cytokines IL-17A, IL-17F, and IL-22 (Marwaha et al., 2012),
which in turn can result in bone destruction via osteoclastic
activation (Sato et al., 2006). Increased levels of IL-17 have
been found in the synovium of RA patients and correlate with
disease severity (Cascao et al., 2010). Furthermore, CIA mouse
models have demonstrated increased Th17 production and
large quantities of IL-17 in lymph nodes draining the affected
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TABLE 2 | Identified microbiome perturbations in RA.
Study Microbiome Methodology Findings
Scher et al., 2012 Oral V1-V2 16S rRNA sequencing Prevotella spp. and letotrichia spp. were enriched in NORA
Mankia et al., 2019 Oral Shotgun metagenomic sequencing Increased prevalence of periodontitis and P. gingivalis in ACPA+ at-risk
individuals.
Scher et al., 2013 Gut V1-V2 16S rRNA sequencing,
Shotgun metagenomic sequencing
in a subset of patients
Higher abundance of Prevotella copri in NORA
Zhang et al., 2015 Oral and Gut Shotgun metagenomic sequencing Higher abundance of Lactobacillus salivarius in RA patients. Prevotella copri
was a function of disease duration.
Round et al., 2011 Oral V4 16S rRNA sequencing Higher abundance of Prevotella spp. in at risk RA population
Rodrigues et al., 2019 Gut qPCR Higher abundances of Bacteroides spp. and Prevotella spp.
Jeong et al., 2019 Gut Genus specific 16S rRNA PCR Higher abundances of Bacteroidales and Provotella in early RA
Maeda et al., 2016 Gut V5-V616S rRNA sequencing Higher abundances of Prevotella copri in a subset of RA patients.
Breban et al., 2017 Gut V3- V416S rRNA sequencing Lower abundance of Prevotellaceae and Paraprevotellaceae in RA than
healthy controls
Vaahtovuo et al., 2008 Gut 16S rRNA hybridization Lower abundance of Bifidobacteria and bacteria of the
Bacteroides-Porphyromonas-Prevotella group, Bacteroides fragilis
subgroup, and Eubacterium rectale–Clostridium coccoides group
compared to fibromyalgia patients
Muñiz Pedrogo et al., 2019 Gut Shotgun metagenomic sequencing Higher abundances of Clostridiaceae in RA group (arthritis group also
contained IBD patients with arthralgia)
Chiang et al., 2019 Gut V1-V3 16S rRNA sequencing ACPA-positive patients had higher proportions of Blautia, Akkermansia, and
Clostridiales than ACPA-negative patients
Picchianti-Diamanti et al., 2018 Gut V3-V4 16S rRNA sequencing Higher abundance of lactobacillales in RA. ACPA positivity was indirectly
correlated with Streptococcaceae, Erysipelotrichaceae, Streptococcus,
Bacteroides xylanisolvens, and Lachnospira pectinoschiza
Forbes et al., 2018 Gut V4 16S rRNA sequencing Higher abundance of Actinomyces, Eggerthella, Clostridium III,
Faecalicoccus, and Streptococcus in all disease cohorts including RA
joints in mice infected with P. gingivalis PD (Sato et al., 2017;
Tsukasaki et al., 2018).
The oral microbiome itself can produce an array of small
molecules, some of which share structural homology to self-
antigens which may lead to antibody cross reactivity and
aberrant targeting of host proteins (i.e., molecular mimicry).
Again P. gingivalis has been implicated here as its α-enolase
protein shares 82% homology to human α-enolase and have been
shown to cross-react (Lundberg et al., 2008). Alpha-enolase is
consistently identified as an autoantigen (Kinloch et al., 2005)
in RA patients. Interestingly higher levels of antibodies against
citrullinated α-enolase (anti-CEP-1) were present in individuals,
without RA, suffering from chronic PD compared to non PD
individuals (De Pablo et al., 2014).
Neutrophil extracellular traps (NETs) primarily act as a
defensive mechanisms against invading microorganisms (Kaplan
and Radic, 2012). During the process of NETosis the extracellular
membrane breaks down allowing the mixing of cellular contents
including chromatin and histones proteins with extracellular
fluid, creating a matrix capable of affixing invading organisms
(Li et al., 2010; Lood et al., 2016). The process of NETosis
has recently gained renewed interest in RA (Khandpur et al.,
2013), as citrullination of proteins is a key step in NETosis.
This process is catalyzed by PAD4 enzymes (Wang et al.,
2009) and interestingly individuals suffering from autoimmune
conditions display spontaneous NETosis, resulting in the
externalization of a number of intracellular molecules which are
subsequently recognized as autoantigens (Grayson and Kaplan,
2016; Demoruelle et al., 2017).
Although we have initially stated the microbiome enacts its
autoimmune effects via the mucosal surface, which is typically
distant to the target tissues, recently both the oral and gut
microbiome have been implicated in the translocation of bacteria
to the joints. Clinical microbiologists now appreciate that a
transient bacteraemia can occur following minor breaks in the
mucosal barrier, including brushing ones’ teeth (Maharaj et al.,
2012). The possibility of bacterial translocation is increased in the
presence of mucosal inflammation such as PD where organisms
associated with PD have been identified in the liver and spleen
of affected mice (Tsukasaki et al., 2018). Additionally P. gingivalis
has been shown to persist intracellularly (Li et al., 2008), which
may then act as a vehicle to carry this pathogen to joint sites.
This hypothesis is supported by the isolation of P. gingivalis DNA
from the synovium of RA patients (Totaro et al., 2013) suggesting
certain bacteria may have a direct inflammatory effect on the
joint. If this effect exists it is independent for ACPA as there
was no correlation between joint bacteria and ACPA positivity. A
summary of possible mechanisms of microbial influence on RA
development is provided in Table 1.
THE GUT MICROBIOME AND RA
The advent of DNA analyses has expanded our knowledge
on the microbiota present within the gut, allowing for the
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identification of communities but also potential functional
pathways. For example, the human microbiome project has
produced >70 million 16S rRNA gene sequences (HMP
consortium) and together with MetaHIT a European
project has suggested great medical significance of the gut
microbiome and aimed at developing genomic databases
for the enumeration of bacteria. A delicate balance has
evolved to create a mutually beneficial relationship between
man and microbe representing a symbiosis within the gut.
However, we now know alterations in our gut microbiome
(dysbiosis) have been linked to a variety of diseases including
RA. The change from symbiosis to dysbiosis is a critical
transition from microbiome stability to an alternative
state, representative of disease. Investigations into the role
of the gut microbiome in the development of RA have
focused on identifying perturbations in the gut microbiome,
thereby resulting in a local mucosal immune dysregulation
which may lead to local inflammation and subsequently
systemic inflammation.
The gut microbiome has evolved its own unique innate
immune homeostasis, with distinct phenotypic expression
between gut and blood borne macrophages. CD14 expression
is lacking on intestinal macrophages, a key molecule required
for the recognition of lipopolysaccharide on bacterial surfaces
(Smith et al., 1997). There is also a distinct down regulation of
cytokine expression from macrophages isolated from the colon
(Smith et al., 2001). Germ-free animal studies have demonstrated
a reduced ability of neutrophils to phagocytise and subsequently
release superoxide anions into the lysosome (Ohkubo et al.,
1990). Innate lymphoid cells capable of helper T (Th) cell
regulation via cytokine production play a vital role in immune
homeostasis. These cells resemble Th17 cells with respect to
their cytokine profile, producing pro-inflammatory interleukins
(IL)-17 and IL-22. Additionally, the gut microbiome plays a
regulatory role for the adaptive immune response. CD4+ T cells
are divided into four major classes depending on their cytokine
profile; Th1, Th2, Th17, and T regulatory Cells (Treg) and a
careful balance of pro versus anti-inflammatory cells maintain
immune homeostasis. Certain bacteria have been associated with
the induction of a T cell response, for example Bacteroides fragilis
induce the differentiation of Treg cells through polysaccharide A
present on the bacterial surface resulting in an anti-inflammatory
effect that has been shown to have both local mucosal effect
but also modulate systemic anti-inflammatory role (Hooper and
Macpherson, 2010; Round et al., 2011). Similarly, Clostridia spp.
(IV and XIVa) have also shown anti-inflammatory effects via
IL-10 producing Treg cells after colonization of germ cell mice
(Atarashi et al., 2011). The gut microbiome has also been shown
to have a pro-inflammatory effect mediated via CD4+ cells
differentiation in Th17, this differentiation is induced via the
presence of SFB (Ivanov et al., 2009).
Given the interplay described and the multiplicative effect
via cytokine activity it is reasonable to assume a pivotal role
of the gut microbiome in autoimmune conditions. Germ-free
animal studies of HLA B27 positive rats (genetic predisposition)
demonstrate that without the input from the gut microbiome
peripheral joint disease does not develop (Taurog et al.,
1994). Gnotobiotic studies implicate specific bacteria in RA
development, moncolonisation with Lactobacillus bifidus results
in homeostatic imbalance between Treg and Th17 (Abdollahi-
Roodsaz et al., 2008). Ivanov et al. (2009) demonstrated a role
for SFB specifically candidatus spp. resident in the terminal ileum
capable to inducting Th17 cell differentiation and subsequent
arthritis development.
Biofilm formation within the gut is now receiving more
interest as a mechanism of immune dysregulation, tipping the
scales between Th17 and Treg cells. Dalpke et al. (2006) described
the activation of TLR-9 via bacterial cell contents including
DNA, a major constituent of bacterial biofilms (Schlafer et al.,
2017). Interestingly biofilm formation has been implicated in the
development of systemic lupus erythematosus (SLE), where a
structural protein of the biofilm called a curli (amyloid fibril) was
capable of binding to bacterial DNA, creating an immunogenic
complex inducing an immune response via DC presentation
(Gallo et al., 2015). Curli fibers produced by common enteric
organisms can activate the NLRP3 inflammasome, leading to
the production of IL-1β through caspase 1 and TLR signaling
thereby driving a pro-inflammatory response (Rapsinski et al.,
2015). However, Curli fibers also have demonstrated the ability to
increase epithelia tight junctions (Oppong et al., 2015) via TLR-2
activation and so further work must be done to explore the action
of biofilm on autoimmunity. Mucosal epithelial barrier integrity
has been linked to RA pathogenesis in mouse models by Chen
et al. (2016), who demonstrated colonization with collinsella spp.
increased mucosal barrier permeability and Th17 cells. Elements
known to influence the mucosal barrier integrity include bacteria,
their by-products and diet (Horta-Baas et al., 2017; Guerreiro
et al., 2018). Microbial by-products particularly short chain fatty
acids (SCFA), including acetate, propionate, and butyrate have
been linked to amelioration of arthritis development in CIA
models (Mizuno et al., 2017; Kim et al., 2018). Mizuno et al.
(2017) showed that oral administration of SCFA was able to
decrease disease severity by decreasing Th1 cells, and increasing
Treg cells thereby damping the immune response.
The RA Dysbiosis
Using 16S rRNA gene sequencing the microbiome of new onset
RA patients, chronic RA patients who are already receiving
treatment, established psoriatic arthritis patients and healthy
matched controls were analyzed. An overabundance of P. copri
with new onset RA was found, a predominance of this group
was not seen within the microbiome’s of long standing arthritis
patients or healthy matched controls (Scher et al., 2013).
Functional genomic analysis of the new onset RA patients
suggests a decrease in vitamin metabolism (biotin, pyroxidal, and
folate) due to a lack of these pathways in Prevotella sp. This
functional shift may represent a pro-inflammatory environment
more resistant to treatment given that folate metabolism is a
target for methotrexate, a stable in RA treatment. Interestingly
Scher et al. demonstrated an inverse relationship between
the abundance of P. copri and the presence of HLA-DRB1.
The authors’ hypothesize a minimum threshold of P. copri is
needed to induce disease, which may be lower in those with
accompanying genetic risk, although this theory has been recently
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challenged by Wells et al. (2020), discussed further in the causality
section of the review. Using metagenomic shotgun sequencing
Zhang et al. demonstrated increased quantities of lactobacillus
spp. in RA patients at multiple microbiome sites (gut, oral and
saliva) which positively correlated with disease activity. P. copri
abundance was illustrated, within the first year, to be a function
of disease duration. Large clustering was identified including
Gordonibacter pamelaeae, Clostridium asparagiforme, Eggerthella
lenta, and Lachnospiraceae bacterium, and smaller clusters
containing Lactobacillus spp., Bifidobacterium dentium and
Ruminococcus lactaris as over-abundant in the RA microbiome
(Zhang et al., 2015).
Recently Alpizar-Rodriguez et al. (2019b) also identified an
over-abundance of P. copri in individuals at risk of RA, their
population included ACPA positive and/or RF positive patients
without arthritis comparing them to first degree seronegative
relatives. This study demonstrates a dysbiotic microbiome before
the onset of clinical arthritis and suggests the gut microbiome
may play an active role in RA development. Of note, this study
did include individuals with undifferentiated arthritis (likely to
include SpA patients) which represents progression of the disease
phenotype beyond the pre-arthritis “at-risk” phase (Alpizar-
Rodriguez et al., 2019b). Multiple studies describing various
dysbiotic bacterial states associated with RA have been published,
some demonstrating increased Prevotellaecae (Maeda et al., 2016;
Jeong et al., 2019; Lee et al., 2019; Rodrigues et al., 2019), some
decreased prevotellaecae (Vaahtovuo et al., 2008; Breban et al.,
2017) and others attributing the dysbiosis to other organisms,
such as Clostridiaceae (Muñiz Pedrogo et al., 2019) Blautia,
Akkermansia, and Clostridiales (Chiang et al., 2019), lactobacilli
(Liu et al., 2013; Picchianti-Diamanti et al., 2018), Actinomyces,
Eggerthella (Chen et al., 2016; Forbes et al., 2018). Table 2
contains a summary of microbial perturbations found in RA.
LUNG MICROBIOME AND RA
Pulmonary disease is a common extra-articular manifestation
of RA and may affect multiple respiratory structures including
lung parenchyma, pleura, airways and vascular compartments
(O’dwyer et al., 2013; Shaw et al., 2015). As previously
stated, smoking is a well-established risk factor for RA, and
often the presence of respiratory symptoms predates the onset
of joint disease. Indeed HRCT has demonstrated underlying
lung pathology prior to RA onset (Demoruelle et al., 2012).
Furthermore, the presence of autoantibodies in the sputum
of seronegative individuals (Willis et al., 2013) suggests the
lung may act as a site of autoantibody generation. Scher
et al. (2016) demonstrated decreased alpha diversity of the
lung microbiome (bronchial alveolar lavage) in individuals
with newly diagnosed RA compared to healthy controls. The
microbial changes identified by Scher et al. (2016) in this
cohort resembled the changes present in the lung microbiome of
sarcoidosis patients (granulomatous disease not associated with
ACPA positivity); involving decreases in the relative abundance
of Burkholderiaceae, Actinomycetaceae, Spirochaetaceae and the
genera Actinomyces, Treponema, and Porphyromonas suggesting
a commonality within lung dysbiosis driving inflammation. Of
note, there was also a correlation between the presence of the
genus Prevotella in BAL samples and systemic RF titers and the
number of ACPA fine specificities.
While there is a distinct lack of lung microbiome studies in
RA or pre-RA, both Prevotella and P. gingivalis have also been
identified within the lung microbiome (Erb-Downward et al.,
2011; Goleva et al., 2013) of other inflammatory conditions
and therefore it is not impossible to assume they could be
present within the RA/Pre-RA population. Both Streptococcus
pneumoniae and Streptococcus pyogenes are capable of causing
respiratory infections, similar to P. gingivalis, both of these
pathogens express α-enolase (Pancholi and Fischetti, 1998;
Bergmann et al., 2001) and therefore via molecular mimicry could
result in ACPA formation within the lung mucosa. It is interesting
to note also the number of respiratory infections has been shown
to increase prior to the onset of RA (Arleevskaya et al., 2018)
and subside upon RA diagnosis and treatment. Additionally, as
smoking induces human PAD genes (PAD2 and PAD4) which
increases the overall burden of citrullinated proteins (Kilsgård
et al., 2012; Damgaard et al., 2015), it has been demonstrated
that citrullinated IL-37 resulted in decreased activity against
common respiratory pathogens potentially facilitating bacterial
infection within the lungs (Kilsgård et al., 2012). Therefore
interplay between lifestyle factors and infections could induce
autoimmunity with the lung.
CAUSALITY AND THE MICROBIOME
In building the case for the microbiome as a trigger of RA we
have relied on several key experimental approaches, specifically
aimed at understanding the molecular mechanisms by which
the microbiome could trigger autoimmunity. In summary these
findings suggest a number of “commensal” organisms capable of
inducing ACPA formation, or microbial perturbation resulting
in activation and subsequent compensatory immune cascades
which could ultimately lead to RA development. Traditional
approaches for the assessment of microbial causal relationships
required the fulfillment of Koch postulates (Koch, 2010; Duhe,
2011), however these postulates pose a significant hurdle for
microbiome studies. Not least of which, the difficulty to
culture much of the human microbiome (Browne et al., 2016),
furthermore we now appreciate the human host microbiome
interactions can be both beneficial or deleterious depending
on the organisms abundance and temporality (Cho and Blaser,
2012) which forfeits the major tenants of Koch’s postulates.
An alternative approach to help ascribe causality is the use of
epidemiology in complex ecosystems like humans, where the
putative casual factor is the environment, or in this case, the
microbiome. Consideration of the environment as a potential
instigator of disease, which may be communicable is integral to
the many sights from the field of epidemiology. For example,
John Snow considered the father of epidemiology and his
description of contaminated drinking water and cholera, to more
complex relations of diet and cardiovascular disease or smoking
and lung cancer. Epidemiological studies of this nature are
expensive and require multiple statistical methods to control for
confounders. Furthermore, these latter examples are unpinned
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by genetics, amongst other factors, and from this perspective
microbial perturbations as an impetus from RA would be highly
contextual. As we have highlighted earlier in this article, cross-
sectional observational studies have demonstrated microbial
changes in individuals with RA and pre-RA compared to healthy
controls, with animal studies supporting a casual role for the
microbiome and RA development. Of course, it is essential to
determine the microbiome features that are causal for RA onset
from those that are a consequence of the disease process or
treatment, and from those that show statistical association due
to confounding.
Mendelian randomization (MR) is increasingly used to
overcome the multiple confounding effects of observational
studies and has been used as an alternative method to
ascribe causality (Sekula et al., 2016; Davies et al., 2018).
MR relies on the presence of naturally occurring genetic
variants within our human genome, and assigns these as
instrumental variables to investigate the effects of a modifiable
risk factor (the microbiome) on a disease outcome (RA). Valid
genetic instrumental variables for RA studies must fulfill three
assumptions; the selected gene must be associated with the
microbiome (relevance assumption), must not be associated
with any related confounders (independence assumption), and
does not affect RA except through the microbiome (exclusion
restriction assumption) (Davies et al., 2018). The nature of
genetic inheritance which allows the use of randomization
introduced during meiosis and fixed at conception allows genetic
variants to act as plausible instrumental variables. Inamo has
used MR to investigate for a causal relationship between the gut
microbiome and RA (Inamo, 2019). Utilizing two datasets from
genome-wide association studies; one for the gut microbiome
as the exposure and another for RA as the outcome, 26 single
nucleotide polymorphisms (SNP) were identified to be associated
with decreased gut microbial diversity. One SNP (rs1230666) was
found to be independently associated with RA development and
therefore removed, following its removal the remaining 25 SNP’s
failed to demonstrate the microbiome as a casual factor for RA
development (Inamo, 2019), suggesting the observed microbial
dysbiosis in RA is a secondary phenomenon. However, Alpizar-
Rodriguez et al. (2019a) has highlighted that microbial dysbiosis
does not always equate to decreases in microbial taxa, and rather
is it a compositional shift of the microbiome that is driving the RA
dysbiosis (Kishikawa et al., 2020). Therefore MR analysis based a
selection of SNP’s that are known to affect the gut microbiome by
decreasing the numbers of taxa present within the gut is unlikely
to yield a casual effect, given an arbitrary decrease of taxa is in
contradiction to the current observational studies.
Using the same datasets as Inamo, lee again used MR to
question the causal effects of the microbiome on RA (Lee, 2020).
In this study 32 SNPs were identified as instrumental variables,
as opposed to original 26 identified by Inamo, presumably by
including SNP’s known to alter bacterial taxa in either direction,
not limiting to those that decrease bacterial taxa only. Following
removal of rs1230666 SNP, known to independently influence
RA development, the MR analysis did show significance and
supported a casual role for the microbiome in RA development.
The use of MR to assign causality to the gut microbiome
obviously relies upon the selected SNPs and the strength of
their influence on the microbiome, Rothschild et al. (2018) has
demonstrated that genetics have a poor effect on microbiome
composition. However, a recent study by Wells et al. (2020) has
demonstrated that a polygenic risk score for RA was positively
associated with the presence of Prevotella spp. within the gut
microbiome of non-RA patients, they went on to validate
their findings within an independent cohort composed of first
degree relatives of RA patients carrying the HLA DRB1 risk
allele. An inverse relationship between P. copri and HLA DRB1
has previously been reported (Scher et al., 2013), here the
authors’ suggest the differences identified are likely a result of
population characteristics or unmeasured confounding (Wells
et al., 2020). They also found an association between individuals
with preclinical RA and P. copri.
Interestingly, there was no association between the polygenic
risk score and overall microbial diversity (Wells et al., 2020),
again adding weight to the theory that MR analysis based
on decreased taxa is unlikely to be an accurate measure
of RA dysbiosis.
FUTURE CONSIDERATIONS
There is much interest in the microbiome community to
move past the traditional taxonomic description of the
microbiome to understanding its functional capacity, which
has mainly relied upon metagenomic sequencing which is
expensive [although methods to infer function from 16S rRNA
are available (Ortiz-Estrada et al., 2019)]. Recently Hillmann
et al. (2018) described shallow shotgun sequencing, allowing
better taxonomic resolution and functional analysis for a
fraction of the cost of whole metagenome shotgun sequencing,
although if wishing to identify the rarer taxa which may
delineate a disease phenotype then depending on research
budget 16S rRNA may still be the better option. It is worth
pointing out that some RA studies have relied upon qPCR to
identify microbes of interest, which obviously identifies only
the organisms carrying the reciprocal primer target sequence,
which might create a skewed view of the microbiome in
these individuals; it is possible that in the future qPCR might
be the technology that is taken to the clinic if a unique
microbiome signature indicative of RA disease was identified,
but we are not at that stage yet. It has been over 10 years
since the first publication of the human microbiome project
(Turnbaugh et al., 2007), which has been consolidated by large
phenotyped cross-sectional population studies (Falony et al.,
2016; Zhernakova et al., 2016). These studies highlight the
importance to account for multiple covariates into microbiome
research such as diet, gut transit time, medications and
intrinsic factors, to date no such RA study has included these
important factors and this is a key point that needs to be
addressed moving forward.
As we have highlighted in this review mucosal surfaces
including oral, gut and lung microbiomes can play an important
role in initiating and perpetuating inflammation. It appears
that induction of autoimmunity may not occur at a single
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site but in fact these microbiomes may be acting in tandem
creating a systemic multiplicative effect. A recent study by
Schmidt et al. (2019) demonstrated that extensive transmission
of bacterial species exists between the oral and gut mucosal sites,
demonstrating >40% of bacterial species were prevalent (>10%)
in both gut and salivary samples in a population including RA
patients. Taken into account future microbiome studies should
investigate a homogenous at-risk population, incorporate known
factors effecting the microbiome, examine multiple mucosal sites,
and ideally provide a longitudinal prospective as individuals
progress toward the disease phenotype.
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